Clinical trials
Active, not recruiting Phase 2/3 Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daehwa Pharmaceutical Co., Ltd. | 1 |
| Fudan University | 1 |
| Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair | 1 |
| Hebei Medical University Fourth Hospital | 1 |
| Hoffmann-La Roche | 1 |
| Semmelweis University | 1 |
| The Netherlands Cancer Institute | 1 |
| Thomas Hatschek | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 8 |
| Hyperthermia | 1 |
| Recurrence | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.